Growth, Share, Opportunities & Competitive Analysis, 2025 – 2032" report has been added to the Credence Research Inc. offering.
In 467 consecutive patients with ALL (0-20 years), we compared RNA sequencing (RNAseq), fluorescence in situ hybridization (FISH), reverse transcriptase polymerase chain reaction (RT-PCR), karyotyping ...
The decreasing cost of DNA sequencing has contributed to an uptick in genomic sequencing for precision diagnostics in rare diseases. The future of precision medicine in rare diseases was explored in a ...
Collaboration, partnership, and clinical integration are key.
Cancer researchers and clinicians are driven by a shared goal – to improve patient quality of life and survival by developing and implementing the most effective treatments and diagnostic tools. Given ...
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer
Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project Several studies have indicated that broad ...
The Sepsis Diagnostics Market has emerged as a critical segment within the global healthcare and in-vitro diagnostics ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. At Illumina’s Genomics Forum conference this fall, former ...
The "Exosome Diagnostic and Therapeutics Market - Growth, Share, Opportunities & Competitive Analysis, 2025 - 2032" report has been added to the Credence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results